Your browser doesn't support javascript.
loading
Standard units for cannabis dose: Why is it important to standardize cannabis dose for drug policy and how can we enhance its place on the public health agenda?
López-Pelayo, Hugo; Matrai, Silvia; Balcells-Olivero, Mercè; Campeny, Eugènia; Braddick, Fleur; Bossong, Matthijs G; Cruz, Olga S; Deluca, Paolo; Dom, Geert; Feingold, Daniel; Freeman, Tom P; Guzman, Pablo; Hindocha, Chandni; Kelly, Brian C; Liebregts, Nienke; Lorenzetti, Valentina; Manthey, Jakob; Matias, João; Oliveras, Clara; Pons, Maria Teresa; Rehm, Jürgen; Rosenkranz, Moritz; Swithenbank, Zoe; van Deurse, Luc; Vicente, Julian; Vuolo, Mike; Wojnar, Marcin; Gual, Antoni.
Affiliation
  • López-Pelayo H; Grup Recerca Addiccions Clínic (GRAC-GRE). Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic Barcelona, Barcelona 08036, Spain. Electronic address: hlopez@clinic.cat.
  • Matrai S; Grup Recerca Addiccions Clínic (GRAC-GRE). Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic Barcelona, Barcelona 08036, Spain.
  • Balcells-Olivero M; Grup Recerca Addiccions Clínic (GRAC-GRE). Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic Barcelona, Barcelona 08036, Spain.
  • Campeny E; Grup Recerca Addiccions Clínic (GRAC-GRE). Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic Barcelona, Barcelona 08036, Spain.
  • Braddick F; Grup Recerca Addiccions Clínic (GRAC-GRE). Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic Barcelona, Barcelona 08036, Spain.
  • Bossong MG; Department of Psychiatry, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, the Netherlands.
  • Cruz OS; University Institute of Maia - ISMAI and Interdisciplinary Research Centre for Human Rights - JusGov, University of Minho- Avenida Carlos de Oliveira Campos, 4475-690 Maia, Portugal and JusGov - Escola de Direito, Campus de Gualtar, Braga 4710-057, Portugal.
  • Deluca P; King's College London, Addictions Department, Institute of Psychiatry, Psychology & Neuroscience, London SE5 8BB, United Kingdom.
  • Dom G; Collaborative Antwerp Psychiatric Research Institute (CAPRI), Antwerp University (UA), Belgium. European Federation of Addiction Societies (EUFAS), Belgium.
  • Feingold D; Psychology Department, Ariel University, Ariel, Israel.
  • Freeman TP; Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, United Kingdom.
  • Guzman P; Grup Recerca Addiccions Clínic (GRAC-GRE). Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic Barcelona, Barcelona 08036, Spain.
  • Hindocha C; Clinical Psychopharmacology Unit, Research Department of Clinical and Health Psychology, University College London, London WC1E 7HB, United Kingdom; NIHR University College London Hospitals Biomedical Research Centre, University College Hospital, London, United Kingdom.
  • Kelly BC; Departament of Sociology, Purdue University, United States.
  • Liebregts N; Bonger Institute of Criminology, University of Amsterdam, the Netherlands.
  • Lorenzetti V; School of Behavioural & Health Sciences Faculty of Health Sciences, Australia.
  • Manthey J; Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Chemnitzer Str. 46, Dresden 01187, Germany; Center for Interdisciplinary Addiction Research of Hamburg University (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE),
  • Matias J; European Monitoring Centre for Drugs and Drug Addiction, Portugal.
  • Oliveras C; Grup Recerca Addiccions Clínic (GRAC-GRE). Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic Barcelona, Barcelona 08036, Spain.
  • Pons MT; Grup Recerca Addiccions Clínic (GRAC-GRE). Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic Barcelona, Barcelona 08036, Spain.
  • Rehm J; Institute for Mental Health Policy Research & Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Canada; Dalla Lana School of Public Health and Department of Psychiatry, University of Toronto (UofT), Canada; Epidemiological Research Unit, Technische
  • Rosenkranz M; Center for Interdisciplinary Addiction Research (ZIS) of Hamburg University, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Martinistraße 52, Hamburg 20246, Germany.
  • Swithenbank Z; Public Health Institute, Liverpool John Moores University, Exchange Station Tithebarn Street, Liverpool L2 2QP, United Kingdom.
  • van Deurse L; Student Governance and Leadership in European Public Health, Maastricht University, the Netherlands.
  • Vicente J; European Monitoring Centre for Drugs and Drug Addiction, Portugal.
  • Vuolo M; Department of Sociology, The Ohio State University, Columbus, OH, United States.
  • Wojnar M; Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland; University of Michigan, Ann Arbor, MI, United States.
  • Gual A; Grup Recerca Addiccions Clínic (GRAC-GRE). Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic Barcelona, Barcelona 08036, Spain.
Int J Drug Policy ; 97: 103350, 2021 11.
Article in En | MEDLINE | ID: mdl-34246016
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cannabis / Pharmaceutical Preparations / Hallucinogens Limits: Humans Language: En Journal: Int J Drug Policy Journal subject: SAUDE PUBLICA / TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cannabis / Pharmaceutical Preparations / Hallucinogens Limits: Humans Language: En Journal: Int J Drug Policy Journal subject: SAUDE PUBLICA / TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Year: 2021 Document type: Article